e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
New models for treating airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cell therapy by adipose stromal cells affect tracheal responsiveness and inflammatory responses in guinea pigs model of COPD
Mohammad Hossein Boskabady (Mashhad, Islamic Republic of Iran), Mohammad Hossein Boskabady, Azadeh Feizpour, Ahmad Ghorbani
Source:
International Congress 2015 – New models for treating airway diseases
Session:
New models for treating airway diseases
Session type:
Poster Discussion
Number:
3570
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mohammad Hossein Boskabady (Mashhad, Islamic Republic of Iran), Mohammad Hossein Boskabady, Azadeh Feizpour, Ahmad Ghorbani. Cell therapy by adipose stromal cells affect tracheal responsiveness and inflammatory responses in guinea pigs model of COPD. Eur Respir J 2015; 46: Suppl. 59, 3570
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Evaluation of apoptosis in inflammatory cells in a model of chronic airway inflammation in guinea pigs: effects of dexamethasone and montelukast treatments
Source: Eur Respir J 2003; 22: Suppl. 45, 281s
Year: 2003
Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Mast cells in COPD airways: relationship to bronchodilator responsiveness and angiogenesis
Source: Eur Respir J 2012; 39: 1361-1367
Year: 2012
Adipose derived stem cells ameliorate airway inflammation in mouse models of asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Effect of mast cells degranulation blockade on the inflammatory response outcome in the COPD model
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Disease specific effects of adrenomedullin in COPD and asthma derived human bronchial epithelial cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Assessment of eosinophils in the bone marrow and airway wall of guinea pigs with chronic lung inflammation: modulation by different ways of oral induced tolerance
Source: Eur Respir J 2004; 24: Suppl. 48, 349s
Year: 2004
Attenuation of acethylcholine and antigen-induced lung parenchyma responsiveness by oral tolerance: a study in a model of chronic airway inflammation in guinea pigs
Source: Eur Respir J 2004; 24: Suppl. 48, 350s
Year: 2004
Differential response of COPD bronchial epithelium to LPS in a three-dimensional culture model
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006
The effect of vitamin D therapy on airway reactivity and airway inflammation in asthmatic children
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013
Treatment: how does inflammatory phenotype influence response to treatment in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007
AZD7624, an inhaled p38 inhibitor for COPD, attenuates lung and systemic inflammation after LPS Challenge in humans
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
Source: Eur Respir Rev 2015; 24: 204-215
Year: 2015
Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Aerobic training reverses airway inflammation by increasing the expression of anti-inflammatory cytokines by peribronchial cells but not by skeletal muscle
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Increased vimentin expression in human primary bronchial epithelium reconstituted in vitro from patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept